Indacaterol: a comprehensive review
A Rossi, G Polese - International Journal of Chronic Obstructive …, 2013 - Taylor & Francis
At present there is no cure for chronic obstructive pulmonary disease (COPD). However,
some nonpharmacologic treatments, such as rehabilitation and lung volume reduction …
some nonpharmacologic treatments, such as rehabilitation and lung volume reduction …
Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium
P Colthorpe, T Voshaar, T Kieckbusch… - Journal of drug …, 2013 - Taylor & Francis
Objectives: The long-acting muscarinic antagonist (LAMA) glycopyrronium (NVA237) has
recently been approved as a once-daily treatment for COPD. The objectives of this study …
recently been approved as a once-daily treatment for COPD. The objectives of this study …
Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients
RM Mroz, L Minarowski, E Chyczewska - Respiratory Regulation-The …, 2013 - Springer
Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory condition,
involving airways and lung parenchyma. The disease leads to airflow limitation, and …
involving airways and lung parenchyma. The disease leads to airflow limitation, and …
Current pharmacotherapy for COPD
JF Donohue, MC Miles, JA Ohar - Indacaterol: The First Once-daily Long …, 2013 - Springer
In this chapter, we are reviewing the current pharmacotherapy available for the treatment of
chronic obstructive pulmonary disease (COPD). Both short-acting and long-acting …
chronic obstructive pulmonary disease (COPD). Both short-acting and long-acting …
[PDF][PDF] Utilization of LABAs versus SABAs in Albanian Insured Outpatients with COPD during 2008-2012
A Sina, Z Shabani - Mediterranean Journal os Social …, 2013 - pdfs.semanticscholar.org
Introduction: Inhaled β2-agonists as bronchodilators are commonly used in Chronic
Obstructive Pulmonary Disease (COPD). These drugs can be either short-acting (SABA) or …
Obstructive Pulmonary Disease (COPD). These drugs can be either short-acting (SABA) or …